PRODUCT DETAIL

Everolimus Krka 10 mg

Code

8511C

MA number

44/0246/18-S

Product Form:

tbl 90x10 mg (blis.OPA/Al/PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EG	Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG02	Everolimus

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	03.08.2018
SPC:	SPC_Everolimus Krka 10 mg_06.2023.pdf
PIL:	PIL_Everolimus Krka 10 mg_06.2023.pdf
Safety feature	Yes
Data update:	06.06.2023